Immuneering (IMRX) Return on Assets (2021 - 2024)

Immuneering (IMRX) has 4 years of Return on Assets data on record, last reported at 0.81% in Q3 2024.

  • For Q3 2024, Return on Assets fell 37.0% year-over-year to 0.81%; the TTM value through Sep 2024 reached 0.81%, down 37.0%, while the annual FY2023 figure was 0.49%, 14.0% down from the prior year.
  • Return on Assets reached 0.81% in Q3 2024 per IMRX's latest filing, down from 0.69% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.2% in Q4 2021 and bottomed at 0.81% in Q3 2024.
  • Average Return on Assets over 4 years is 0.43%, with a median of 0.44% recorded in 2023.
  • Peak YoY movement for Return on Assets: decreased -9bps in 2023, then plummeted -37bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 0.2% in 2021, then plummeted by -94bps to 0.4% in 2022, then dropped by -28bps to 0.51% in 2023, then tumbled by -60bps to 0.81% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.81% in Q3 2024, 0.69% in Q2 2024, and 0.58% in Q1 2024.